Minnesota FOIA #P011127101

Engineering antigen-specific regulatory T cells for use in type 1 diabetes (Phase 3)

This purchase order from TWIN_CITIES to the University of British Columbia in Vancouver, BC, Canada, awards $200,125 for research involving engineering antigen-specific regulatory T cells for use in type 1 diabetes (Phase 3). The order covers a single lot of the specified research product, with the award date on June 7, 2024. The vendor is the University of British Columbia, located at 2222 Health Sciences Mall, Vancouver, BC, Canada. The procurement appears to be a research contract with no specified contract duration, and the award is part of a scientific research initiative. Likely competitors include companies specializing in cellular therapies and diabetes research.

Description

Engineering antigen-specific regulatory T cells for use in type 1 diabetes (Phase 3)